Conférences & Key notes

    1. Population PK/PD and the rational design of an antimicrobial dosage regimen in veterinary medicine  by PL Toutain. In: 2nd International Conference on Antimicrobial Agents in Veterinary Medicine (AAVM)  Congress  June 2004   Ottawa, Canada.

    2. Le médicament vétérinaire et le médicament humain : similitudes, différences et enjeux de santé publique par PL Toutain; In: Congrès de Physiologie,de Pharmacologie et de Thérapeutique; 11-13 avril 2007 à Toulouse France.

    3. Allometric scaling to predict pharmacokinetic and pharmacodynamic parameters in man by PL Toutain; In: Médicaments en pédiatrie: apport de la modélisation 5-6 juillet 2007  à Paris.

    4. Use of Monte Carlo simulations to select PK/PD breakpoints and therapeutic doses for antimicrobials in veterinary medicine by PL Toutain ; In :3th à International Conference on Antimicrobial Agents in Veterinary Medicine (AAVM) May 16-20, 2006 Orlando, FL USA

    5. Plasma vs. tissue concentrations to predict antibiotic efficacy by PL Toutain; 4th International Conference on Antimicrobial Agents in Veterinary Medicine (AAVM) 24-28 August 2008 Prague, Czech Republic

    6. Bioequivalence : some challenges and issues by PL Toutain  in: EMEA/ CVMP/CMDVmeeting 2008  Paris France

    7. PK/PD integration in veterinary drug development : an overview by PL Toutain ; In: EMEA Focus group meeting on PK/PD 24 September 2008 London UK

    8. Le médicament vétérinaire et le bien-être animal. PL Toutain ; INRA ; conférences sur le Bien être Animal  2008 Paris

    9. Les Bonnes Pratiques de Laboratoire (BPL) : le pour et le contre dans les décisions publiques avec le cas du bisphénol . PL Toutain ; In: conférence SFSTP ENVT 24 avril 2009 Toulouse

    10. PK/PD approach for antibiotics :- tissue or blood drug level to predict antibiotic efficacy by PL Toutain ; 11th Congress International congress of the European Association for Veterinary Pharmacology and Toxicology (EAVPT) Leipzig,12-16 July 2009 Germany

    11. Contrôle antidopage & contrôle des médications chez le cheval par PL Toutain ; Comité Régional d’Equitation Midi-Pyrénées ; soirée débat du 2 novembre 2009 ENVT Toulouse

    12. Prophylaxis & Metaphylaxis in Veterinary Antimicrobial Therapy ; Alain Bousquet-Mélou . In: 5th International Conference on antimicrobial agents in veterinary medicine Congress 2010 , Tel Aviv Israel

    13. Generic antimicrobials ; American Academy of Veterinary Pharmacology and Therapeutics by PL Toutain ; In: Bioequivalence workshop ; 2010 Potomac, USA

    14. Should licking behavior be factored into topical product bioequivalence trials ? by PL Toutain ; American Academy of Veterinary Pharmacology and Therapeutics ; Bioequivalence workshop ; 2010 Potomac, USA

    15. Festschrift in honour of Professor Peter Lees by PL toutain ; The Royal Veterinary , College Camden Campus : 22nd July 2010 London UK

    16. How to use irrelevant plasma and urine drug concentration in doping control in the FEI by PL toutain ; Lausanne 16 &17 août 2010

    17. Predictive value of PK/PD drug modelling : application to a analgesic drugs by PL Toutain ;In: 13th World Congress on Pain, 30 August 2010 Montreal Canada.

    18. Effects of Early Versus Late Treatments by Marbofloxacin in a Mouse-Model of Pasteurella multocida Pulmonary Infection. by A Bousquet-Mélou; In:  ARAE 28 Juin 2011 Tours France

    19. Consequences of generic marketing on antibiotic consumption and the spread of resistance : facts and hypotheses by PL Toutain ; In : The responsible use of antibiotics in animals, 14-16 November 2011 Egmond ann Zee The netherlands

    20. The prudent use of antibiotics in veterinary medicine : the right drug, the right time, the right dose & the right duration of treatment by PL Toutain . In: The Bunge y Born foundation,18th November 2011 Tandil, Argentina

    21. How to establish a dosage regimen for a sustainable use of antibiotics in veterinary medicine by PL Toutain ;In: 12th International congress of the European Association for Veterinary Pharmacology and Toxicology ; 8-12 July 2012 Noordwijkerhout ; The Netherland

    22. What are the public health issues that practitioners have to consider to enforce a sustainable use of antibiotics by PL Toutain ;12th International congress of the European Association for Veterinary Pharmacology and Toxicology (EAVPT) ; 8-12 July 2012 Noordwijkerhout ; The Netherland as PPTSame conference as PDF

    23. Clinical pharmacology of corticosteroids in horses and doping control by PL Toutain ; 15-22 September 2012 ; ICRAV , Philadelphia, USA

    24. Veterinary medicine needs innovative antibiotics to fit public health requirements ; by PL Toutain; Train-ASAP 12 October 2012 Copenhagen, Denmark

    25. Are we over-rating the risk of low-dose drug exposure on the selection of resistant strains ; by PL Toutain; AAVM 2012 Washington USA

    26. Bisphenol A (BPPA) pharmacokinetics across species ;by PL Toutain; NIEHS BPA grantee Research Meeting January 28-29 2013 Research Triangle Park, NC USA

    27. Licking behavior affects the disposition of macrocyclic lactone pour-on formulations in cattle by PL Toutain;  Food & Drug Administration 2005 (update 2015) Washingon USA

    28. La recherche scientifique dans les écoles vétérinaires françaises :-un état des lieux vu par les indices bibliométriques entre 2000 et 2010 par PL Toutain ENVT Toulouse

    29. Choix d’un antibiotiques et d’un schéma posologique. Traiter vite, fort, longtemps, est-ce toujours d’actualité ? Par A Bousquet-Mélou 4ème Journée Vétérinaire Bretonne 18 Février 2014

    30. L’antibiothérapie pour les nuls – par PL Toutain AVEF février 2014 Roissy, France

    31. Antimicrobial Therapy in Animals and Public Health. Early Treatments With Inoculum-Size-Adjusted Doses to Conciliate Control of Infectious Diseases, Reduction of Antibiotic Consumption and Prevention of Antimicrobial Resistance in Commensal Flora by A Bousquet-Mélou. ECVPT Meeting Amsterdam 27-28 February 2014

    32. Conférence donnée par Roland Darré lors de l’attribution du nom Emmanuel Leclainche à l’amphithéâtre d’honneur de l’Ecole Nationale Vétérinaire de Toulouse le 22 juin 2014

    33. Quelles sont les stratégies thérapeutiques pour limiter le développement des résistances bactériennes ? Par A Bousquet-Mélou Journée Quizz “EcoAntibio en production porcine” Rennes 02 Juillet 2014

    34. PK/PD Approach and antimicrobial resistance by PL Toutain ; 7th International Conference on Antimicrobial Agents in Veterinary Medicine (AAVM) Berlin September 16-19,2014

    35. Antimicrobial therapy in horses : a pharmacologist perspective by PL Toutain ; Department of Veterinary Disease Biology 10 Octobre 2014 University of Copenhagen

    36. Antibiorésistance : enjeux de santé publique et conséquences pour la santé animale. Par A Bousquet-Mélou Journée Ecoantibio Toulouse 06 Novembre 2014

    37. Computation of withdrawal period (time): meat & milk by PL Toutain. University of Melbourne 14 February 2014, Australia.

    38. Strategies to avoid the risk of antimicrobial resistance in veterinary medicine by PL Toutain pour le  Jubilé du Pr Johanna Fink-Gremmels Utrecht.Ter gelegenheid van het emeritaat  van Johanna Fink-gremmels Utrecht, NL 1 0 july 2014

    39. Choix d’un antibiotique. Les critères PK/PD : comment s’en servir ? Par A Bousquet-Mélou AFVAC Paris 13 Novembre 2014

    40. Population pharmacokinetics and Monte Carlo simulation for setting MIC breakpoints for antimicrobial susceptibility testing. The case of amoxicillin in pigs. Par A Bousquet-Mélou ARAE Tours 1er Juillet 2015

    41. The ideal antibiotic in veterinary medicine. By PL Toutain ; ICOHAR 2 October 2015 Copenhagen Denmark & 21 October 2015 CSVPT Congress Changsa China

    42. PK/PD for antibiotics : an overview. by PL Toutain ; 8 October 2015 ; Huazhong Agricultural University at Wuhan, China

    43. PK/PD for antibiotics : blood or tissular concentrations ? by PL Toutain 8 October 2015 ; Huazhong Agricultural University at Wuhan China

    44. How to establish a dosage regimen for antibiotics. by PL Toutain 9 October 2015 ; Huazhong Agricultural University at Wuhan, China

    45. Metaphylaxis vs. curative treatments for antibiotics : why we need different dosage regimens by PL Toutain ;9 October 2015 ; Huazhong Agricultural University at Wuhan; China

    46. Antimicrobial Susceptibility Testing (AST) and how to establish a clinical breakpoint : CLSI/VAST vs. EUCAST/VETCAST approaches . by PL Toutain 12 October 2015 ; Huazhong Agricultural University at Wuhan; China

    47. Antimicrobial Susceptibility Testing (AST) for amoxicillin in pigs : the setting of the PK/PD cutoff values using population kinetics and Monte Carlo Simulations. by PL Toutain 12 October 2015 ; Huazhong Agricultural University at Wuhan China

    48. How population PK/PD improve the evaluation and the use of veterinary drugs. by PL Toutain ;12 October 2015 ; Huazhong Agricultural University at Wuhan, China

    49. PK/PD integration in drug development by PL Toutain 18 October 2015 ; Workshop on the R&D of new pharmaceutical for animals uses. Huazhong Agricultural University at Wuhan ; par PL Toutain ; China

    50. PK/PD of Non Steroidal Anti-inflammatory drugs by PL Toutain ;13 October 2015 ; Huazhong Agricultural University at Wuhan China

    51. PK/PD for corticosteroids by PL Toutain ;13 October 2015 ; Huazhong Agricultural University at Wuhan China

    52. Experimental design and data analysis for bioequivalence trials. Par PL Toutain ;19 October 2015 ; Workshop on the R&D of new pharmaceutical for animals uses. Huazhong Agricultural University at Wuhan China

    53. La bonne utilisation des antibiotiques. Par A Bousquet-Mélou CongrA?s National Alterbiotique Nantes 14 Octobre 2015

    54. Veterinary medicine needs news green antimicrobials ;par PL Toutain ; Eight International Conference on Antimicrobial Agents in veterinary medicine 25 août 2016 Budapest Hungaria

    55. Tout ce qu’un praticien devrait savoir pour mettre en oeuvre une antibiothérapie raisonnée chez le porc : partie I : les questionnements. par PL Toutain ; Association des vétérinaires de l’industrie ; 21 octobre 2016 Québec Canada

    56. Tout ce qu’un praticien devrait savoir pour mettre en oeuvre une antibiothérapie raisonnée chez le porc : partie II : les solutions. par PL Toutain ; Association des vétérinaires de l’industrie ; Québec Canada 21 octobre 2016

    57. Antibiorésistances humaine & vétérinaire, enjeux de santé publique et principes de solution. par PL Toutain ;22 octobre 2016  Congrès vétérinaire québécois. Québec Canada

    58. La résistance aux antibiotiques : les grands enjeux sociétaux. Tournefeuille, conférence grand public donnée au Phare 30/01/2017 par PL Toutain

    59. PK/PD: an introduction with the case of antimicrobials by PL Toutain; VMAS symposium/workshop Uppsala 13 December 2017

    60. Overview on determination of ECOFF, PK/PD breakpoints ,clinical cut-offs and the setting of Clinical breakpoint by VetCAST by PL Toutain; VMAS symposium/workshop Uppsala 13 December 2017

    61. What is a MIC? Relationship between a MIC and conventional pharmacodynamic parameters  by  PL Toutain; VMAS symposium/workshop Uppsala 13 December 2017

    62. Dose extrapolation from in vitro to in vivo and across species by PL Toutain October  2017 Wuhan University China

    63. Population modelling in veterinary medicine : an introduction by PL Toutain October 2017 Wuhan University China

    64. PK &PD POP data analysis & interpretation: the florfenicol in calves as an example by PL Toutain October  2017 Wuhan University China

    65. les médicaments génériques : Partie 1 : science et polémiques par PL Toutain Master parcours santé 22 février 2018

    66. Les médicaments génériques :Partie 2 : Bioéquivalence par PL Toutain Master parcours santé 22 février  2018

    67. Colloque ABR Innovations Limoges 030419

    68. Population PK & PD for veterinary medicine: goals value and limits.
       And how population PK/PD improve the evaluation and clinical use of veterinary drugs. By PL Toutain; Australian & New Zealand College of Veterinary Scientists QT Gold Coast, Surfers Paradise,2018; Australia

    69.  PK/PD approach for antibiotics: tissue, biophase or blood drug level to predict antibiotic efficacy. By PL Toutain; Australian & New Zealand College of Veterinary Scientists QT Gold Coast, Surfers Paradise,2018, Australia 

    70. Drugs, pharmacokinetics and their dosing in critical patient with a special emphasis on antibiotics. By PL Toutain; Australian & New Zealand College of Veterinary Scientists QT Gold Coast, Surfers Paradise,2018, Australia

    71. Endectocides pour-on formulations: an individual topical or collective oral modality of drug administration in cattle. By PL Toutain; Australian & New Zealand College of Veterinary Scientists QT Gold Coast, Surfers Paradise,2018, Australia

    72. PK/PD and medication/doping control in horses: the EU approach
       or a PK/PD approach to propose irrelevant plasma or urine drug concentrations for medication & doping control. By PL Toutain; Australian & New Zealand College of Veterinary Scientists QT Gold Coast, Surfers Paradise,2018, Australia


    73.  Design of a dosage regimen that least selects for resistance. By PL Toutain; Australian & New Zealand College of Veterinary Scientists QT Gold Coast, Surfers Paradise, Australia

    74. How to extrapolate a dose? (Within & between species and from in vitro to in vivo). By PL Toutain; Australian & New Zealand College of Veterinary Scientists QT Gold Coast, Surfers Paradise, Australia

    75. Optimization of antibiotic use to minimise resistance and maximize clinical efficacy. by PL Toutain; Australian & New Zealand College of Veterinary Scientists QT Gold Coast, Surfers Paradise, Australia.

    76. Analyzing the impact of antimicrobials on the commensal microbiota.By PL Toutain;  Australian & New Zealand College of Veterinary Scientists QT Gold Coast, Surfers Paradise, Australia.

    77. Antimicrobial Susceptibility Testing: past, present, future, value & limits.by PL Toutain; Australian & New Zealand College of Veterinary Scientists QT Gold Coast, Surfers Paradise, Australia.

    78. Generic drugs: issues and pitfalls. By PL Toutain; Australian & New Zealand College of Veterinary Scientists QT Gold Coast, Surfers Paradise, Australia.

    79.   Veterinary pharmacotherapy: trends and expectations for the future by PL Toutain. In: 24-27 JUNE WROCLAW, POLAND EAVPT 2018

    80. Optimization of antibiotic use to minimise resistance and maximize clinical efficacy: an update 2019 By PL Toutain. Congress of the Chinese Society of Veterinary pharmacology and toxicology October 13-16; Lanzhou, Gansu province,2019, China.

    81. Levothyrox : science, réglementation, média et patients par PL toutain, La maison de la philosophie,  29 Janvier 2020 Toulouse

       

    82. A history of antimicrobial drugs in animals: Evolution and revolution